Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy

Authors:

Open Access

Publisher website

19 April 2022

journal article
correction
Published by Springer Nature in Cell Death & Disease

Vol. 13 (4) , 1-2
DOI:10.1038/s41419-022-04743-7
PMID:35440079
PMCID:PMC9018877

Abstract

No abstract available

Keywords

Cited by 3 articles